CXCL10 and neoplasm: Additionally, upregulation of EZH2 expression causes CXCL9 and CXCL10 downregulation, decreasing T cell recruitment to the tumor, and promotes the tumor cells to undergo transformation to a more mesenchymal phenotype[126-132].